PlexusDx maps 14 pathways and 49 peptides across 150+ genetic insights, helping your provider tailor not only your semaglutide dose but also recommend whether L-carnitine, exercise modifications, or dietary shifts will deliver the strongest results for your unique biology
Semaglutide drives glucose-stimulated insulin secretion through sustained GLP-1R activation in pancreatic beta cells and producing the characteristic incretin biology of cAMP-PKA-EPAC2 pathway activation, KATP channel closure potentiation, L-type calcium channel activation, and calcium-triggered insulin exocytosis enhancement across the about one-week pharmacokinetic window
This is after extensive research showed promising results for the use of semaglutide for weight loss
Dual action Works on GLP-1 and GIP receptors two related metabolic signals FDA-approved Established prescription medication with labeled indications and monitoring How it helps Dual pathways Activates GLP-1 and GIP Broader metabolic signaling Why it's discussed as "next gen" Appetite Helps reduce hunger signals Supports smaller, satisfying portions Often described as quieter "food noise" Blood sugar Studied for glycemic control Rooted in diabetes medicine Metabolic health is part of the story Titration Started low, increased over time Side-effect management built in Patience is part of the protocol The biology behind Tirzepatide Looping molecular animation from our wellness science series
Second, these drugs act on parts of the brain that help control appetite and cravings